Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS
· Delayed Price · Currency is USD
0.309
0.00 (0.00%)
At close: Dec 5, 2025
Lipella Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 1.86 | 2.18 | 3.29 | 5.12 | 1.41 | 0.61 | Upgrade
|
| Short-Term Investments | - | - | - | - | 0.3 | - | Upgrade
|
| Cash & Short-Term Investments | 1.86 | 2.18 | 3.29 | 5.12 | 1.71 | 0.61 | Upgrade
|
| Cash Growth | 37.09% | -33.67% | -35.69% | 198.75% | 182.56% | 2233.15% | Upgrade
|
| Other Receivables | - | 0.08 | 0.03 | 0.11 | - | 0.07 | Upgrade
|
| Receivables | - | 0.08 | 0.03 | 0.11 | - | 0.07 | Upgrade
|
| Prepaid Expenses | 0.22 | 0.35 | 0.1 | 0.56 | 0.09 | 0.02 | Upgrade
|
| Total Current Assets | 2.08 | 2.62 | 3.43 | 5.8 | 1.81 | 0.7 | Upgrade
|
| Property, Plant & Equipment | 0.27 | 0.06 | 0.15 | 0.15 | 0.2 | 0.26 | Upgrade
|
| Total Assets | 2.35 | 2.67 | 3.58 | 5.95 | 2.01 | 0.96 | Upgrade
|
| Accounts Payable | 0.46 | 0.39 | 0.14 | 0.38 | 0.05 | 0.02 | Upgrade
|
| Accrued Expenses | 0.14 | 0.32 | 0.16 | 0.46 | 0.23 | 0.11 | Upgrade
|
| Short-Term Debt | - | - | - | 0.28 | 0.03 | 0.03 | Upgrade
|
| Current Portion of Leases | 0.04 | 0.05 | 0.09 | 0.06 | 0.04 | 0.05 | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0 | Upgrade
|
| Total Current Liabilities | 0.64 | 0.75 | 0.39 | 1.18 | 0.34 | 0.21 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.05 | 0.05 | Upgrade
|
| Long-Term Leases | 0.22 | - | 0.05 | 0.1 | 0.17 | 0.21 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.03 | 0.03 | Upgrade
|
| Total Liabilities | 0.86 | 0.75 | 0.43 | 1.27 | 0.59 | 0.49 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 20.72 | 17.26 | 13.47 | 10.38 | 4.53 | 1.7 | Upgrade
|
| Retained Earnings | -19.23 | -15.34 | -10.32 | -5.7 | -3.11 | -1.24 | Upgrade
|
| Total Common Equity | 1.49 | 1.92 | 3.14 | 4.68 | 1.42 | 0.46 | Upgrade
|
| Shareholders' Equity | 1.49 | 1.92 | 3.14 | 4.68 | 1.42 | 0.46 | Upgrade
|
| Total Liabilities & Equity | 2.35 | 2.67 | 3.58 | 5.95 | 2.01 | 0.96 | Upgrade
|
| Total Debt | 0.26 | 0.05 | 0.14 | 0.43 | 0.28 | 0.33 | Upgrade
|
| Net Cash (Debt) | 1.59 | 2.14 | 3.16 | 4.69 | 1.43 | 0.27 | Upgrade
|
| Net Cash Growth | 24.07% | -32.30% | -32.71% | 227.80% | 420.77% | - | Upgrade
|
| Net Cash Per Share | 0.52 | 2.04 | 4.21 | 9.24 | 3.36 | 1.03 | Upgrade
|
| Filing Date Shares Outstanding | 4.62 | 2.55 | 0.78 | 0.72 | 0.48 | 0.48 | Upgrade
|
| Total Common Shares Outstanding | 4.62 | 1.21 | 0.76 | 0.72 | 0.48 | 0.29 | Upgrade
|
| Working Capital | 1.44 | 1.86 | 3.04 | 4.62 | 1.47 | 0.49 | Upgrade
|
| Book Value Per Share | 0.32 | 1.59 | 4.16 | 6.51 | 2.94 | 1.61 | Upgrade
|
| Tangible Book Value | 1.49 | 1.92 | 3.14 | 4.68 | 1.42 | 0.46 | Upgrade
|
| Tangible Book Value Per Share | 0.32 | 1.59 | 4.16 | 6.51 | 2.94 | 1.61 | Upgrade
|
| Machinery | 0.14 | 0.14 | 0.14 | 0.13 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.